Zeus Hygia Unveils Metaberine: The World’s First Green Process, Enriched Berberine Powered by Proprietary Technology

▴ Zeus Hygia
Zeus Hygia Lifesciences, a leading innovator in nutraceutical solutions, today announced the launch of Metaberine®, the world’s first green process enriched berberine developed using proprietary BioSOLVE Technology.

Hello! If you're looking for high-quality genericmedications, fast delivery and excellent customer service, ourstore is the right choice for you. With over 20 years of onlineexperience, we guarantee safe, effective products that are alwaysin stock. Delivery within 48 hours, free shipping from $200, and 100% money-back guarantee if your order doesn't arrive on time.

👉 Order now at BestCheapPills and discover exclusive discounts for registeredcustomers!

Hyderabad, 1t8th August, 2025: Zeus Hygia Lifesciences, a leading innovator in nutraceutical solutions, today announced the launch of Metaberine®, the world’s first green process enriched berberine developed using proprietary BioSOLVE Technology. Designed to overcome the limitations of conventional berberine extracts, Metaberine® delivers enhanced solubility, superior bioavailability, and a quicker onset of action all at a significantly lower dose.

The increasing prevalence of sedentary lifestyles and unhealthy dietary habits is contributing to a surge in metabolic disorders, with diabetes now affecting over 800 million adults worldwide. In recent years, GLP-1 receptor agonists have gained popularity for their dual benefits improving glycemic control and aiding in weight management. This dual efficacy addresses the interconnected challenges of diabetes and obesity, making GLP-1 therapies a vital option. However, high costs and limited accessibility of GLP-1 treatments highlight the urgent need for more affordable, effective alternatives. Emerging oral formulations aim to enhance convenience and affordability, and Metaberine® promising faster results at lower doses can help meet this critical need.

Berberine: Benefits and Limitations
Berberine is a naturally occurring alkaloid found in Berberine roots (Indian Barberry) and other plants. It is well-recognized for supporting metabolic health, cardiovascular function, and healthy lipid and glucose metabolism.

Despite its proven benefits, conventional berberine extracts face significant limitations:

  • Poor bioavailability: Less than 2% absorption into the bloodstream
  • High dosage requirement: Typically, 500–1500 mg/day in divided doses
  • Delayed onset of action
  • Gastrointestinal side effects: Including diarrhea, bloating, and nausea
Additionally, its low solubility slows therapeutic impact, making sustained results harder to achieve without long-term, high-dose use.

Metaberine®: A Next-Generation Solution
“Our proprietary BioSOLVE Technology, utilizing a 100% aqueous process, produces a highly uniform, porous powder with dramatically improved solubility and bioavailability,” said Dr. Arunkanth Krishnakumar, Co-founder and CEO of Zeus Hygia. “This innovation allows Metaberine® to deliver results faster, at significantly lower doses—200 mg per day versus the 500–1500 mg typically required with regular extracts—while reducing digestive discomfort.”

Key Advantages of Metaberine®:
  • Enhanced solubility for improved absorption and efficacy
  • Lower daily dosage for better compliance
  • Reduced side-effect risk due to minimal gastrointestinal impact
  • Versatile applications: capsules, sachets, and more
Metaberine® is backed by proprietary bioavailability data, with ongoing human clinical trials planned. It is manufactured at Zeus Hygia, adhering to stringent quality and safety certifications.

“With the global rise in metabolic disorders such as diabetes, obesity, and cardiovascular disease, the demand for effective, natural, and safe interventions is higher than ever,” added Dr. Krishnakumar. “Metaberine® is our solution to that need—a next-generation berberine that redefines efficacy standards in the nutraceutical industry.”

Metaberine® is designed for B2B partners across the global health and wellness ecosystem, including Pharmaceutical companies, Nutraceutical and dietary supplement brands, OTC (over-the-counter) health product makers, Functional food and beverage brands, Contract manufacturers and formulators. By providing a potent, fast-acting, and cost-effective berberine solution, Zeus Hygia enables these partners to develop high-performance metabolic health products for their markets.
Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Smart Operating Rooms: The Future of Hospital OTNovember 21, 2026
Smartphone Diagnostics: Phones as Medical Screening ToolsNovember 21, 2026
AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
Hospital-at-Home in India: Can Technology Deliver Safe Care?November 20, 2026
Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026